9 insiders reported 20 Form 4 transactions for Humacyte, Inc. (HUMA) over the past 18 months (most recent 2026-08-21). Recent activity: Jones Keith Anthony (Director) Buy 10,000 shares, Jones Keith Anthony (Director) Buy 30,000 shares, Sebelius Kathleen (Director) Buy 56,818 shares, Constantino Michael T. (Director) Buy 11,000 shares, Sander Dale A. (CFO and Chief Corp. Dev. Off) Sell 45,887 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Jones Keith Anthony | Director | Buy | 10,000 | $6,930 |
| 2026-08-19 | Jones Keith Anthony | Director | Buy | 30,000 | $17,820 |
| 2026-05-20 | Sebelius Kathleen | Director | Buy | 56,818 | $50,000 |
| 2026-05-20 | Constantino Michael T. | Director | Buy | 11,000 | $9,840 |
| 2026-05-20 | Sander Dale A. | CFO and Chief Corp. Dev. Off | Sell | 45,887 | $41,147 |
| 2026-05-20 | Parikh Shamik J | Chief Medical Officer | Sell | 45,887 | $41,147 |
| 2025-11-17 | Parikh Shamik J | Chief Medical Officer | Buy | 311,100 | $0 |
| 2025-11-17 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 311,100 | $0 |
| 2025-08-20 | Dougan Brady W | Director | Sell | 591,685 | $934,862 |
| 2025-08-20 | Dougan Brady W | Director | Sell | 549,360 | $1.0M |
| 2025-08-20 | Dougan Brady W | Director | Sell | 1.1M | $1.8M |
| 2025-08-20 | Niklason Laura E | President, CEO and Director | Sell | 549,360 | $1.0M |
| 2025-08-20 | Niklason Laura E | President, CEO and Director | Sell | 1.1M | $1.8M |
| 2025-08-20 | Niklason Laura E | President, CEO and Director | Sell | 591,685 | $934,862 |
| 2025-04-15 | Scheessele William John | Chief Commercial Officer | Buy | 6,493 | $9,999 |
| 2025-04-14 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 20,000 | $30,600 |
| 2025-04-14 | Parikh Shamik J | Chief Medical Officer | Buy | 7,500 | $11,625 |
| 2025-04-08 | Green Charles Bruce | Director | Buy | 6,000 | $7,740 |
| 2025-04-08 | Constantino Michael T. | Director | Buy | 16,000 | $20,160 |
| 2025-04-08 | Sebelius Kathleen | Director | Buy | 50,000 | $66,000 |
Source: SEC Form 4 filings · as of 2026-08-21